• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fra-1 通过转录上调受体酪氨酸激酶 AXL 来控制膀胱癌细胞的运动能力。

Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL.

机构信息

Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, UK.

出版信息

Oncogene. 2012 Mar 22;31(12):1493-503. doi: 10.1038/onc.2011.336. Epub 2011 Aug 8.

DOI:10.1038/onc.2011.336
PMID:21822309
Abstract

Fos-related antigen 1 (Fra-1) is a Fos family member overexpressed in several types of human cancers. Here, we report that Fra-1 is highly expressed in the muscle-invasive form of the carcinoma of the bladder (80%) and to a lesser extent in superficial bladder cancer (42%). We demonstrate that in this type of cancer Fra-1 is regulated via a C-terminal instability signal and C-terminal phosphorylation. We show that manipulation of Fra-1 expression levels in bladder cancer cell lines affects cell morphology, motility and proliferation. The gene coding for AXL tyrosine kinase is directly upregulated by Fra-1 in bladder cancer and in other cell lines. Importantly, our data demonstrate that AXL mediates the effect of Fra-1 on tumour cell motility but not on cell proliferation. We suggest that AXL may represent an attractive therapeutic target in cancers expressing high Fra-1 levels.

摘要

Fos 相关抗原 1(Fra-1)是 Fos 家族成员在几种类型的人类癌症中过表达。在这里,我们报告 Fra-1 在肌肉浸润性膀胱癌(80%)中高度表达,在浅表膀胱癌中表达程度较低(42%)。我们证明 Fra-1 在这种类型的癌症中受到 C 末端不稳定性信号和 C 末端磷酸化的调节。我们表明,在膀胱癌细胞系中操纵 Fra-1 的表达水平会影响细胞形态、运动性和增殖。编码 AXL 酪氨酸激酶的基因在膀胱癌和其他细胞系中被 Fra-1 直接上调。重要的是,我们的数据表明 AXL 介导 Fra-1 对肿瘤细胞运动性的影响,但不影响细胞增殖。我们认为 AXL 可能代表高 Fra-1 水平表达的癌症的一个有吸引力的治疗靶点。

相似文献

1
Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL.Fra-1 通过转录上调受体酪氨酸激酶 AXL 来控制膀胱癌细胞的运动能力。
Oncogene. 2012 Mar 22;31(12):1493-503. doi: 10.1038/onc.2011.336. Epub 2011 Aug 8.
2
Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer.人膀胱癌中 c-Met 通过一种独立于 ras 和 Src 的机制激活 Axl 和 PDGFR-α 的转录。
BMC Cancer. 2011 Apr 16;11:139. doi: 10.1186/1471-2407-11-139.
3
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.鉴定乳腺癌中的受体酪氨酸激酶 AXL 为人 miR-34a 微 RNA 的靶标。
Breast Cancer Res Treat. 2011 Nov;130(2):663-79. doi: 10.1007/s10549-011-1690-0. Epub 2011 Aug 4.
4
MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL.MERTK 控制黑色素瘤细胞的迁移和存活,并相对于 AXL 差异化调节细胞行为。
Pigment Cell Melanoma Res. 2013 Jul;26(4):527-41. doi: 10.1111/pcmr.12110. Epub 2013 May 21.
5
Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL.受体酪氨酸激酶 AXL 的激活导致人肺癌细胞恶性进展中的细胞软化。
Sci Rep. 2017 Dec 19;7(1):17770. doi: 10.1038/s41598-017-18120-4.
6
The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells.受体 AXL 使 EGFR 信号多样化,并限制三阴性乳腺癌细胞对 EGFR 靶向抑制剂的反应。
Sci Signal. 2013 Aug 6;6(287):ra66. doi: 10.1126/scisignal.2004155.
7
Gas6 expression and Tyrosine kinase Axl Sky receptors: Their relation with tumor stage and grade in patients with bladder cancer.Gas6 表达和酪氨酸激酶 Axl 受体:它们与膀胱癌患者肿瘤分期和分级的关系。
Arch Ital Urol Androl. 2021 Jun 28;93(2):148-152. doi: 10.4081/aiua.2021.2.148.
8
Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL.长非编码 RNA LINC00526 通过与 AXL 形成双重负反馈环来抑制神经胶质瘤的进展。
J Cell Mol Med. 2019 Aug;23(8):5518-5531. doi: 10.1111/jcmm.14435. Epub 2019 Jun 26.
9
Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL.蛋白S通过调节AXL驱动口腔鳞状细胞癌的致瘤性。
Oncotarget. 2017 Feb 21;8(8):13986-14002. doi: 10.18632/oncotarget.14753.
10
The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.受体酪氨酸激酶 Axl 是前列腺癌增殖和肿瘤生长的重要调节因子,是一个新的治疗靶点。
Oncogene. 2013 Feb 7;32(6):689-98. doi: 10.1038/onc.2012.89. Epub 2012 Mar 12.

引用本文的文献

1
Up-regulation of NGEF via the BRAF /ERK/AP1 pathway enhances invasion and migration abilities of BRAF-mutant thyroid cancer.通过BRAF/ERK/AP1途径上调NGEF可增强BRAF突变型甲状腺癌的侵袭和迁移能力。
Biochem Biophys Rep. 2025 Jul 17;43:102164. doi: 10.1016/j.bbrep.2025.102164. eCollection 2025 Sep.
2
Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?自身免疫性疾病和癌症中TAM受体的蛋白水解作用:它向我们传达了什么信息?
Cell Death Dis. 2025 Mar 5;16(1):155. doi: 10.1038/s41419-025-07480-9.
3
FOSL1 transcriptionally dictates the Warburg effect and enhances chemoresistance in triple-negative breast cancer.
FOSL1通过转录调控瓦伯格效应并增强三阴性乳腺癌的化疗耐药性。
J Transl Med. 2025 Jan 2;23(1):1. doi: 10.1186/s12967-024-06014-9.
4
FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer.FOSL1 是一个关键调节因子,它驱动三阴性乳腺癌中 TCOF1 的表达,该表达受超级增强子调控。
Epigenetics Chromatin. 2024 Nov 10;17(1):34. doi: 10.1186/s13072-024-00559-1.
5
The transcription factors NR5A1 and JUNB cooperate to activate the Axl promoter in mouse Sertoli cell lines.转录因子 NR5A1 和 JUNB 合作激活小鼠支持细胞系中的 Axl 启动子。
Mol Biol Rep. 2024 Sep 14;51(1):982. doi: 10.1007/s11033-024-09934-3.
6
20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters.20(S)-人参皂苷Rh2通过抑制LAMC2调节的ABC转运蛋白克服胰腺癌对吉西他滨的耐药性。
J Adv Res. 2024 Sep 11. doi: 10.1016/j.jare.2024.09.006.
7
ERCC1 abundance is an indicator of DNA repair-apoptosis decision upon DNA damage.ERCC1丰度是DNA损伤后DNA修复-凋亡决定的一个指标。
Cell Death Discov. 2024 Jan 25;10(1):47. doi: 10.1038/s41420-024-01817-7.
8
Identification and validation of prognostic signature genes of bladder cancer by integrating methylation and transcriptomic analysis.通过整合甲基化和转录组分析鉴定和验证膀胱癌的预后特征基因。
Sci Rep. 2024 Jan 3;14(1):368. doi: 10.1038/s41598-023-50740-x.
9
Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein.沉默 AHNAK 通过上调 ANXA2 蛋白促进鼻咽癌的进展。
Cell Oncol (Dordr). 2024 Jun;47(3):833-850. doi: 10.1007/s13402-023-00898-3. Epub 2023 Nov 14.
10
Overexpression of FRA1 () Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression.FRA1()的过表达导致全基因组转录失调、细胞黏附能力降低和细胞周期进程改变。
Cells. 2023 Sep 24;12(19):2344. doi: 10.3390/cells12192344.